ZEISS ends successful fiscal year 2012/13
ZEISS has brought fiscal year 2012/13 to a successful conclusion with an all-time high in revenue. The company put in a good performance in some sectors despite a partly difficult economic environment and generated revenue totaling EUR 4.190 billion (prior year: EUR 4.163 billion) and earnings (EBIT) of EUR 335 million (prior year: EUR 420 million).
In fiscal year 2012/13 different developments were observed in the market segments relevant to ZEISS. Overall, the market situation was tense: while slight growth was reported in the market for medical technology, the markets for microscopy, industrial metrology and eyeglass lenses remained stable. Demand in the market for lithography systems continued to decline in the first half of the fiscal year compared to the previous year, but picked up again in the second half. "In fiscal year 2012/13 we reached and partly exceeded our targets. ZEISS put in a good performance despite the challenging business environment and the weakness of the economy at the beginning of the year," said Dr. Michael Kaschke, President and CEO of Carl Zeiss AG. "We made no compromises in our multi-year investment program – the biggest ever in the company's history – but continued to implement it consistently and systematically.“
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Biomarkers indicate health in old age - Researchers can determine the disease vulnerability of older people using a defined set of substances in the blood
New imaging analysis method revolutionizes the diagnosis of head and neck tumors
Significant breakthrough in the chemistry of fluorinated compounds - Overcoming the “Fluoro Wall”: Researchers observe tunneling effect of heavy atoms for the first time
X-rays reveal how glasses lose their stability - PETRA III experiment shows how atoms in glass behave as weaknesses appear
Earlier unknown molecular-level mechanism may contribute to the growth rate of breast cancer
PET points to tau protein as leading culprit in Alzheimer's
Syrris Establish Japanese Subsidiary Office - Syrris Expand Global Sales Network to Match Growing Demand in the Far East
Sartorius reviews fiscal 2008 - Different outlook for the two Group divisions
SGS Australia opens new Sydney Laboratory for Environmental Testing
Thermo Fisher Scientific Announces Partnership with Megaware to Deliver New Bioequivalence Solution
Neandertal genome project reaches its goal - High-quality Neandertal genome provides novel insights into human origins
